Search results
Results from the WOW.Com Content Network
For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why. A ...
U.S. Food and Drug Administration Commissioner Robert Califf defended the agency's role in addressing the country's obesity epidemic as he was grilled by senators over FDA regulation of the food ...
Published in JAMA Health Forum on Friday, the study, "Changes in Adult Obesity Trends in the US," found that between 2022 and 2023, obesity in American adults between ages 26-75 dropped about 0.15%.
[25] A cross-sectional study in China shows that the relationship between BMI and times per week fast food consumption was not significant. [26] Jared Fogle's drastic weight loss on a Subway diet, which is considered a fast food chain, is another case that poses a fair debate against the idea that the culprit of obesity is fast food. Fogle ...
As societies become increasingly reliant on energy-dense fast-food meals, the association between fast food consumption and obesity becomes more concerning. [9] In the United States, consumption of fast food meals has tripled and calorie intake from fast food has quadrupled between 1977 and 1995. [10]
NEW YORK (Reuters) -Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong ...
In the United States, nearly $14 billion is spent per year on advertising by food, beverage, and restaurant companies, and much of this marketing promotes nutritionally poor foods. [5] The Rudd Center works to analyze these food marketing tactics and inform policy efforts to reduce unhealthy food marketing. Additionally, they seek to raise ...
Lilly's drug, tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight management, will cease to be in shortage "very soon," CEO David Ricks said in an interview with Bloomberg in Paris.